Find therapies in clinical trials near you – page 25

Study on Transmural Healing in Patients with Moderate to Severe Crohn's Disease Using Upadacitinib and Drug Combination

Study on Transmural Healing in Patients with Moderate to Severe Crohn's Disease Using Upadacitinib and Drug Combination

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency

Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Study on Baloxavir Marboxil for Children with Influenza

Study on Baloxavir Marboxil for Children with Influenza

Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Study on Etrasimod for Adolescents with Moderate to Severe Ulcerative Colitis

Study on Etrasimod for Adolescents with Moderate to Severe Ulcerative Colitis

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis